GEROADX
LIVE

Serial Number

79400440

Owner

GEROA DIAGNOSTICS S.L.

Attorney

Ramón Andres Urteaga

Filing Date

Apr 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GEROADX Trademark

Serial Number: 79400440 • Registration: 8105539

GEROADX is a trademark filed by GEROA DIAGNOSTICS S.L. on April 10, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GEROA DIAGNOSTICS S.L.

AVENIDA BUDAPEST 50

Entity Type: 99

Trademark Details

Filing Date

April 10, 2024

Registration Date

January 20, 2026

Published for Opposition

December 2, 2025

Goods & Services

Diagnostic preparations for scientific use; diagnostic preparations for use in research laboratories; diagnostic substances, other than those for medical use, namely, for scientific research in the field of neurodegenerative diseases using the salivary biomarker lactoferrin; diagnostic kits comprising specimen receptors in the nature of microplates coated with anti-lactoferrin antibodies and diagnostic reagents for analyzing selected bacteria for purposes of quantifying salivary lactoferrin for scientific research purposes; diagnostic reagents, except for medical or veterinary use

Diagnostic preparations for medical use; diagnostic substances for medical use; medical diagnostic test strips for saliva analysis for the early detection of Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic agents for medical use; diagnostic products for medical use, namely, medical diagnostic reagents and immunoassay kits comprising diagnostic agents, preparations and substances for in vitro quantification of salivary lactoferrin; diagnostic testing materials for medical use, namely, diagnostic test reagents and antibody-coated microplates for in vitro testing for medical use; diagnostic preparations for medical use in medical laboratories; products for medical diagnostics, namely, medical diagnostic reagents, immunoassay kits comprising diagnostic agents, preparations and substances, and diagnostic preparations for the in vitro detection of the salivary biomarker lactoferrin, associated with Alzheimer's Disease and Mild Cognitive Impairment associated with Alzheimer's Disease; diagnostic reagents for medical use; chemical diagnostic reagents for medical use

Automatic saliva biomarker analyzers for medical diagnostic purposes; medical immunochemical diagnostic apparatus for medical use; detector apparatus for medical use in diagnosis namely, diagnostic apparatus for the detection and quantification of salivary lactoferrin as a biomarker associated with Alzheimer's Disease; diagnostic apparatus for measuring for medical use, namely, immunochemical diagnostic testing apparatus for measuring salivary lactoferrin levels as an aid in the early detection of Alzheimer's Disease

Medical analyses for the diagnosis and treatment of people; medical diagnostic services, including medical diagnostic testing and analysis; medical services for the diagnosis of diseases in the human body

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
NOTIFICATION PROCESSED BY IB
Dec 11, 2025 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 3, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 3, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 3, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 31, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2025 GNFN
FINAL REFUSAL E-MAILED
May 1, 2025 GNFR
FINAL REFUSAL WRITTEN
May 1, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 7, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 7, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 31, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 30, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR